cmAngio® vs FEops HEARTguideTM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by FEops

AI Verdict

cmAngio® focuses on early cardiovascular risk assessment by detecting breast arterial calcifications on mammograms. In contrast, FEops HEARTguide™ specializes in pre-procedural planning for structural heart interventions like TAVI and LAAO, utilizing AI and digital twins from CT scans. While both leverage AI in cardiology and radiology, their distinct applications make them suitable for different stages of patient care.

Choose cmAngio® if…

Choose cmAngio® if your primary goal is to leverage existing mammography data for early cardiovascular risk assessment in women. This tool is ideal for integrating AI-powered detection of Breast Arterial Calcifications (BAC) into routine breast screening workflows, providing valuable insights into cardiovascular health without additional radiation or procedures.

View cmAngio® →

Choose FEops HEARTguideTM if…

Choose FEops HEARTguide™ if you require advanced predictive simulation and anatomical insights for planning complex structural heart interventions like TAVI or LAAO. This platform is best suited for optimizing device sizing and positioning pre-procedure, aiming to enhance patient outcomes and procedural efficiency through digital twin technology.

View FEops HEARTguideTM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® FEops HEARTguideTM
Pricing Paid, out-of-pocket Unknown
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® FEops HEARTguideTM
Tool Name cmAngiou00ae FEops HEARTguideu2122
Company CureMetrix FEops nv
Primary Use Case FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
Core AI Function AI-based detection of Breast Arterial Calcifications (BAC) Predictive simulation technology for device-anatomy interaction; AI-based anatomical measurements from CT scans.
Target Medical Area Breast Arterial Calcifications, Cardiovascular Health Structural heart procedure planning (TAVI, LAAO)
Integration Standard Compatible with any DICOM-compliant viewer DICOM interface for easy integration into clinical workflow

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and FEops HEARTguideTM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. FEops HEARTguideTM is a cloud-based AI and digital twin platform for structural heart procedure planning, offering predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. FEops HEARTguideTM uses CT scans for AI-based anatomical measurements and predictive simulations.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology. FEops HEARTguideTM is relevant for Cardiology, Cardiothoracic Surgery, and Radiology.
cmAngiou00ae employs AI software for the detection and visualization of Breast Arterial Calcifications. FEops HEARTguideTM utilizes AI and digital twin technology to provide predictive simulations of device-anatomy interaction and anatomical measurements for structural heart planning.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.